Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease

BACKGROUND: The effects of olmesartan (OLM) on blood pressure and kidney function in Japanese patients with chronic kidney disease (CKD) were compared between 20 mg twice daily (BID) and 40 mg once daily (QD) treatments. METHODS: The subjects were Japanese CKD patients with concurrent hypertension w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Yukinao, Suzuki, Anna, Mugishima, Koji, Sumi, Yuichiro, Otsuka, Yusuke, Otsuka, Tomoyuki, Ohno, Dai, Murasawa, Tsuneo, Tsuruoka, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797633/
https://www.ncbi.nlm.nih.gov/pubmed/24143121
http://dx.doi.org/10.2147/IJNRD.S52905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797633/
https://www.ncbi.nlm.nih.gov/pubmed/24143121
http://dx.doi.org/10.2147/IJNRD.S52905

Ejemplares similares